Across TCGA pan-cancer cohorts, FAM90A5P RNA is linked to patient survival in 1 of 34 cancer types, making it the most broadly survival-associated FAM90A5P data layer.
The strongest signal is observed in stomach adenocarcinoma (STAD), where higher FAM90A5P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated FAM90A5P expression acts as an unfavorable survival marker.
STAD are the cancer types where FAM90A5P RNA most reproducibly stratifies survival.